The recombinant rabbit hemorrhagic disease virus VP60 protein obtained from Pichia pastoris induces a strong humoral and cell-mediated immune response following intranasal immunization in mice

被引:14
作者
Farnos, Omar
Rodriguez, Manuel
Chiong, Maylin
Parra, Francisco
Boue, Oscar
Lorenzo, Norailys
Coldas, Manuel
Lleonart, Ricardo
机构
[1] Ctr Genet Engn & Biotechnol, Anim Biotechnol Div, Havana 10600, Cuba
[2] Univ Oviedo, Dept Bioquim & Biol Mol, Inst Univ Biotecnol Asturias, E-33006 Oviedo, Spain
[3] Ctr Genet Engn & Biotechnol, Phys Chem Div, Havana 10600, Cuba
关键词
VP60; Pichia pastoris; RHDV; intranasal immunization; cellular immune response; recombinant capsid protein;
D O I
10.1016/j.vetmic.2005.11.062
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rabbit hemorrhagic disease (RHD) is a contagious and highly lethal viral disease of rabbits that spreads rapidly and infects animals by nasal, conjunctival and oral routes. Therefore, this experiment was undertaken to study the immune response generated after intranasal (i.n.) vaccination with the recombinant VP60 capsid protein from rabbit hemorrhagic disease virus (RHDV) expressed at high levels in Pichia pastoris. Groups of BALB/c mice were immunized with three doses of purified VP60 protein (Group 1), VP60 formulated within the cell debris fraction of the transformed yeast (Group 2) and placebo (Group 3) by intranasal route. Mice were also intramuscularly injected with purified VP60 protein (Group 4). A rapid antibody response specific against rabbit hemorrhagic disease virus was observed in all the experimental groups, except in Group 3, as detected by ELISA. The highest titers were found 60 days after the first immunization. Mice from Group 1 showed the highest IgG response (p < 0.05) and the most balanced profile of IgG1, IgG2a and IgG2b subclasses. IgA titers specific to the virus were found only in animals from this group, which also developed the highest specific lymphocyte proliferative response. Interferon-gamma (IFN-gamma) and interleukin-12 (IL-12) gene expression was also detected after an ex vivo-specific stimulation of mice from Groups 1 and 4. These data demonstrated the capacity of VP60 protein expressed in R pastoris to elicit a potent humoral and cell-mediated immune response following an intranasal immunization scheme. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:187 / 195
页数:9
相关论文
共 52 条
[1]   Characterization of the HCV core virus-like particles produced in the methylotrophic yeast Pichia pastoris [J].
Acosta-Rivero, N ;
Aguilar, JC ;
Musacchio, A ;
Falcón, V ;
Viña, A ;
de la Rosa, MC ;
Morales, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) :122-125
[2]   HCV core protein modulates the immune response against the HBV surface antigen in mice [J].
Aguilar, JC ;
Acosta-Rivero, N ;
Dueñas-Carrera, S ;
Grillo, JM ;
Pichardo, D ;
Urquiza, D ;
Guillen, G ;
Muzio, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (01) :59-63
[3]  
AGUILAR JC, 1998, PCTCU9900006 CU
[4]  
Berstad AKH, 1997, VACCINE, V15, P1473
[5]   Single-step purification of recombinant Bm86 protein produced in Pichia pastoris by salting-out and by acid precipitation of contaminants [J].
Boue, O ;
Sanchez, K ;
Tamayo, G ;
Hernandez, L ;
Reytor, E ;
Enriquez, A .
BIOTECHNOLOGY TECHNIQUES, 1997, 11 (08) :561-565
[6]   Production and biochemical characterization of the recombinant Boophilus microplus Bm95 antigen from Pichia pastoris [J].
Boué, O ;
Farnós, O ;
González, A ;
Fernández, R ;
Acosta, JA ;
Valdés, R ;
González, LJ ;
Guanche, Y ;
Izquierdo, G ;
Suárez, M ;
Domínguez, I ;
Machado, H ;
Rodríguez, M ;
Lleonart, R .
EXPERIMENTAL AND APPLIED ACAROLOGY, 2004, 32 (1-2) :119-128
[7]   Identification of the virus of rabbit haemorrhagic disease in Tunisia [J].
Bouslama, A ;
DeMia, GM ;
Hammami, S ;
Aouina, T ;
Soussi, H ;
Frescura, T .
VETERINARY RECORD, 1996, 138 (05) :108-110
[8]   Large-scale production in Pichia pastoris of the recombinant vaccine Gavac(TM) against cattle tick [J].
Canales, M ;
Enriquez, A ;
Ramos, E ;
Cabrera, D ;
Dandie, H ;
Soto, A ;
Falcon, V ;
Rodriguez, M ;
delaFuente, J .
VACCINE, 1997, 15 (04) :414-422
[9]   Recent advances in mucosal vaccine development [J].
Chen, HM .
JOURNAL OF CONTROLLED RELEASE, 2000, 67 (2-3) :117-128
[10]  
CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532